Biechele Royce Advisors Eli Lilly & CO Transaction History

Biechele Royce Advisors

$303 Million
Q3 2024

A detailed history of Biechele Royce Advisors transactions in Eli Lilly & CO stock. As of the latest transaction made, Biechele Royce Advisors holds 7,824 shares of LLY stock, worth $6.17 Million. This represents 2.28% of its overall portfolio holdings.

Number of Shares

7,824

Previous 7,824 -0.0%

Holding current value

$6.17 Million

Previous $7.08 Million 2.15%

% of portfolio

2.28%

Previous 2.39%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$724.87 - $909.04 $2,174 - $2,727	-3 Reduced 0.04%	7,824 $7.08 Million
Q3 2023 Nov 01, 2023	BUY	$434.7 - $599.3 $16,953 - $23,372	39 Added 0.5%	7,827 $4.2 Million
Q2 2023 Aug 08, 2023	SELL	$350.74 - $468.98 $153,624 - $205,413	-438 Reduced 5.32%	7,788 $3.65 Million
Q4 2022 Feb 13, 2023	BUY	$321.55 - $374.67 $16,720 - $19,482	52 Added 0.64%	8,226 $3.01 Million
Q3 2022 Nov 10, 2022	BUY	$296.48 - $337.87 $19,271 - $21,961	65 Added 0.8%	8,174 $2.64 Million
Q2 2022 Aug 03, 2022	BUY	$278.73 - $327.27 $241,380 - $283,415	866 Added 11.96%	8,109 $2.63 Million
Q1 2022 May 10, 2022	SELL	$234.69 - $291.66 $187,986 - $233,619	-801 Reduced 9.96%	7,243 $2.07 Million
Q3 2021 Nov 12, 2021	BUY	$221.6 - $272.71 $99,055 - $121,901	447 Added 5.88%	8,044 $1.86 Million
Q4 2020 Feb 04, 2021	SELL	$130.46 - $172.63 $159,030 - $210,435	-1,219 Reduced 13.83%	7,597 $1.28 Million
Q3 2020 Nov 03, 2020	BUY	$146.22 - $169.13 $11,697 - $13,530	80 Added 0.92%	8,816 $1.31 Million
Q2 2020 Jul 30, 2020	BUY	$136.42 - $164.18 $3,274 - $3,940	24 Added 0.28%	8,736 $1.43 Million
Q3 2019 Oct 18, 2019	SELL	$106.79 - $116.16 $106,790 - $116,160	-1,000 Reduced 10.3%	8,712 $974,000
Q3 2018 Oct 30, 2018	SELL	$85.86 - $107.31 $8,586 - $10,731	-100 Reduced 1.02%	9,712 $1.04 Million
Q1 2018 Apr 20, 2018	BUY	$74.21 - $87.6 $6,530 - $7,708	88 Added 0.9%	9,812 $759,000
Q4 2017 Feb 08, 2018	BUY	$81.94 - $87.89 $796,784 - $854,642	9,724	9,724 $821,000

Others Institutions Holding LLY

# of Institutions

4,007

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $749B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Biechele Royce Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Biechele Royce Advisors with notifications on news.

Account

Biechele Royce Advisors Eli Lilly & CO Transaction History